Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06533397
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-24
Brief Title:
The Application of a Biphasic Calcium Sulfate Graft Material in Sinus Floor Elevation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Application of a Biphasic Calcium Sulfate Graft Material in Sinus Floor Elevation
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Pneumatization of the maxillary sinus may lead to insufficient bone volume for dental implant placement in the edentulous posterior maxilla Sinus floor elevation SFE surgery with the lateral window technique is a safe and predictable surgical intervention to restore bone height in the maxillary premolar and molar areas According to the literature several bone graft materials may be successfully applied for SFE surgery There is a lack of evidence regarding the application of biphasic calcium sulfate BCS for SFE The healing period following staged SFE is 2-9 months
The aim of this study is
to evaluate the success of SFE surgery using BCS as graft material
to compare the microarchitecture of the augmented bone depending on the healing period
to evaluate the success of dental implants placed in the augmented bone and that of the prostheses delivered on the dental implants
The aim of this study is
to evaluate the success of SFE surgery using BCS as graft material
to compare the microarchitecture of the augmented bone depending on the healing period
to evaluate the success of dental implants placed in the augmented bone and that of the prostheses delivered on the dental implants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None